Stock Earnings

Question 1

Aspire Biopharma Holdings Inc 的关键财务报表是什么？

Accepted Answer

根据最新的财务报表（Form-10K），Aspire Biopharma Holdings Inc 的总资产为 $6，净loss为 $-12

Question 2

ASBP 的关键财务比率是什么？

Accepted Answer

Aspire Biopharma Holdings Inc 的流动比率是 0.4，净利 margin 为 0，每股销售为 $0。

Question 3

Aspire Biopharma Holdings Inc 的收入按细分市场或地理位置如何划分？

Accepted Answer

Currently Aspire Biopharma Holdings Inc data is not available.

Question 4

Aspire Biopharma Holdings Inc 是否盈利？

Accepted Answer

no，根据最新的财务报表，Aspire Biopharma Holdings Inc 的净loss为 $-12

Question 5

Aspire Biopharma Holdings Inc 有负债吗？

Accepted Answer

yes，Aspire Biopharma Holdings Inc 的负债为 15

Question 6

Aspire Biopharma Holdings Inc 的流通股有多少？

Accepted Answer

Aspire Biopharma Holdings Inc 的总流通股为 7.76

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2020
Revenue	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--
Cost of Revenue	--	--	--	--	--
Gross Profit	--	--	--	--	--
Selling, General & Admin	15	3	1	0	--
Research & Development	0	--	--	--	--
Operating Expenses	16	3	1	0	--
Other Non Operating Income (Expenses)	-8	-9	--	--	--
Pretax Income	-27	-12	4	3	--
Income Tax Expense	--	--	--	--	--
Net Income	-27	-12	4	3	--
Net Income Growth	800%	-400%	33%	--	--
Shares Outstanding (Diluted)	49.33	8.24	19.17	31.68	--
Shares Change (YoY)	483%	-56.99%	-39%	--	--
EPS (Diluted)	-0.55	-1.52	0.23	0.11	--
EPS Growth	48%	-753%	112%	--	--
Free Cash Flow	-2	-2	0	-1	--
Free Cash Flow Per Share	-0.04	-0.24	0	-0.03	--
Gross Margin	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	--
Free Cash Flow Margin	0%	0%	0%	0%	--
EBITDA	--	--	--	--	--
EBITDA Margin	--	--	--	--	--
D&A For EBITDA	--	--	--	--	--
EBIT	-16	-3	-1	0	0
EBIT Margin	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--

Aspire Biopharma Holdings Inc (ASBP) Price